Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Intervalo de año de publicación
1.
Neuron ; 102(3): 602-620.e9, 2019 05 08.
Artículo en Inglés | MEDLINE | ID: mdl-30902550

RESUMEN

The rich functional diversity of the nervous system is founded in the specific connectivity of the underlying neural circuitry. Neurons are often preprogrammed to respond to multiple axon guidance signals because they use sequential guideposts along their pathways, but this necessitates a strict spatiotemporal regulation of intracellular signaling to ensure the cues are detected in the correct order. We performed a mouse mutagenesis screen and identified the Rho GTPase antagonist p190RhoGAP as a critical regulator of motor axon guidance. Rather than acting as a compulsory signal relay, p190RhoGAP uses a non-conventional GAP-independent mode to transiently suppress attraction to Netrin-1 while motor axons exit the spinal cord. Once in the periphery, a subset of axons requires p190RhoGAP-mediated inhibition of Rho signaling to target specific muscles. Thus, the multifunctional activity of p190RhoGAP emerges from its modular design. Our findings reveal a cell-intrinsic gate that filters conflicting signals, establishing temporal windows of signal detection.


Asunto(s)
Orientación del Axón/genética , Receptor DCC/metabolismo , Proteínas Activadoras de GTPasa/genética , Neuronas Motoras/metabolismo , Músculo Esquelético/inervación , Netrina-1/metabolismo , Proteínas Represoras/genética , Animales , Células del Asta Anterior/metabolismo , Ratones , Células Madre Embrionarias de Ratones , Mutación
2.
Nat Protoc ; 12(1): 104-131, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27977023

RESUMEN

Systemic application of therapeutics to the CNS tissue often results in subtherapeutic drug levels, because of restricted and selective penetration through the blood-brain barrier (BBB). Here, we give a detailed description of a standardized technique for intrathecal drug delivery in rodents, analogous to the technique used in humans. The intrathecal drug delivery method bypasses the BBB and thereby offers key advantages over oral or intravenous administration, such as maximized local drug doses with minimal systemic side effects. We describe how to deliver antibodies or drugs over several days or weeks from a s.c. minipump and a fine catheter inserted into the subdural space over the spinal cord (20 min operative time) or into the cisterna magna (10 min operative time). Drug levels can be sampled by quick and minimally invasive cerebrospinal fluid (CSF) collection from the cisterna magna (5 min procedure time). These techniques enable targeted application of any compound to the CNS for therapeutic studies in a wide range of CNS disease rodent models. Basic surgery skills are helpful for carrying out the procedures described in this protocol.


Asunto(s)
Cisterna Magna , Inyecciones Espinales/métodos , Preparaciones Farmacéuticas/administración & dosificación , Espacio Subdural , Animales , Conducta Animal/efectos de los fármacos , Catéteres , Cisterna Magna/metabolismo , Femenino , Inyecciones Espinales/instrumentación , Masculino , Preparaciones Farmacéuticas/metabolismo , Ratas , Espacio Subdural/metabolismo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA